Report cover image

Global Immobilized Lipase Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Feb 07, 2025
Length 194 Pages
SKU # APRC20034289

Description

Summary

According to APO Research, the global Immobilized Lipase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Immobilized Lipase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Immobilized Lipase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Immobilized Lipase market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Immobilized Lipase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Immobilized Lipase market include Syncozymes, Yili Chuannig Biotechnology, Amicogen, ChiralVision, Novozymes, Beijing Global Biologicals and Qingdao Weilan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immobilized Lipase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Immobilized Lipase, also provides the sales of main regions and countries. Of the upcoming market potential for Immobilized Lipase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immobilized Lipase sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Immobilized Lipase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Immobilized Lipase sales, projected growth trends, production technology, application and end-user industry.

Immobilized Lipase Segment by Company

Syncozymes
Yili Chuannig Biotechnology
Amicogen
ChiralVision
Novozymes
Beijing Global Biologicals
Qingdao Weilan Bio
Immobilized Lipase Segment by Type

Encapsulation
Covalent Bonding
Adsorption
Cross-linking
Immobilized Lipase Segment by Application

Pharmaceuticals
Food
Chemicals
Others
Immobilized Lipase Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Immobilized Lipase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Immobilized Lipase market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Immobilized Lipase significant trends, drivers, influence factors in global and regions.
6. To analyze Immobilized Lipase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immobilized Lipase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immobilized Lipase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immobilized Lipase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immobilized Lipase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immobilized Lipase industry.
Chapter 3: Detailed analysis of Immobilized Lipase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Immobilized Lipase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Immobilized Lipase in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Immobilized Lipase Sales Value (2020-2031)
1.2.2 Global Immobilized Lipase Sales Volume (2020-2031)
1.2.3 Global Immobilized Lipase Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Immobilized Lipase Market Dynamics
2.1 Immobilized Lipase Industry Trends
2.2 Immobilized Lipase Industry Drivers
2.3 Immobilized Lipase Industry Opportunities and Challenges
2.4 Immobilized Lipase Industry Restraints
3 Immobilized Lipase Market by Company
3.1 Global Immobilized Lipase Company Revenue Ranking in 2024
3.2 Global Immobilized Lipase Revenue by Company (2020-2025)
3.3 Global Immobilized Lipase Sales Volume by Company (2020-2025)
3.4 Global Immobilized Lipase Average Price by Company (2020-2025)
3.5 Global Immobilized Lipase Company Ranking (2023-2025)
3.6 Global Immobilized Lipase Company Manufacturing Base and Headquarters
3.7 Global Immobilized Lipase Company Product Type and Application
3.8 Global Immobilized Lipase Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Immobilized Lipase Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Immobilized Lipase Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Immobilized Lipase Market by Type
4.1 Immobilized Lipase Type Introduction
4.1.1 Encapsulation
4.1.2 Covalent Bonding
4.1.3 Adsorption
4.1.4 Cross-linking
4.2 Global Immobilized Lipase Sales Volume by Type
4.2.1 Global Immobilized Lipase Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Immobilized Lipase Sales Volume by Type (2020-2031)
4.2.3 Global Immobilized Lipase Sales Volume Share by Type (2020-2031)
4.3 Global Immobilized Lipase Sales Value by Type
4.3.1 Global Immobilized Lipase Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Immobilized Lipase Sales Value by Type (2020-2031)
4.3.3 Global Immobilized Lipase Sales Value Share by Type (2020-2031)
5 Immobilized Lipase Market by Application
5.1 Immobilized Lipase Application Introduction
5.1.1 Pharmaceuticals
5.1.2 Food
5.1.3 Chemicals
5.1.4 Others
5.2 Global Immobilized Lipase Sales Volume by Application
5.2.1 Global Immobilized Lipase Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Immobilized Lipase Sales Volume by Application (2020-2031)
5.2.3 Global Immobilized Lipase Sales Volume Share by Application (2020-2031)
5.3 Global Immobilized Lipase Sales Value by Application
5.3.1 Global Immobilized Lipase Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Immobilized Lipase Sales Value by Application (2020-2031)
5.3.3 Global Immobilized Lipase Sales Value Share by Application (2020-2031)
6 Immobilized Lipase Regional Sales and Value Analysis
6.1 Global Immobilized Lipase Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Immobilized Lipase Sales by Region (2020-2031)
6.2.1 Global Immobilized Lipase Sales by Region: 2020-2025
6.2.2 Global Immobilized Lipase Sales by Region (2026-2031)
6.3 Global Immobilized Lipase Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Immobilized Lipase Sales Value by Region (2020-2031)
6.4.1 Global Immobilized Lipase Sales Value by Region: 2020-2025
6.4.2 Global Immobilized Lipase Sales Value by Region (2026-2031)
6.5 Global Immobilized Lipase Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Immobilized Lipase Sales Value (2020-2031)
6.6.2 North America Immobilized Lipase Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Immobilized Lipase Sales Value (2020-2031)
6.7.2 Europe Immobilized Lipase Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Immobilized Lipase Sales Value (2020-2031)
6.8.2 Asia-Pacific Immobilized Lipase Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Immobilized Lipase Sales Value (2020-2031)
6.9.2 South America Immobilized Lipase Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Immobilized Lipase Sales Value (2020-2031)
6.10.2 Middle East & Africa Immobilized Lipase Sales Value Share by Country, 2024 VS 2031
7 Immobilized Lipase Country-level Sales and Value Analysis
7.1 Global Immobilized Lipase Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Immobilized Lipase Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Immobilized Lipase Sales by Country (2020-2031)
7.3.1 Global Immobilized Lipase Sales by Country (2020-2025)
7.3.2 Global Immobilized Lipase Sales by Country (2026-2031)
7.4 Global Immobilized Lipase Sales Value by Country (2020-2031)
7.4.1 Global Immobilized Lipase Sales Value by Country (2020-2025)
7.4.2 Global Immobilized Lipase Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.5.2 USA Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.6.2 Canada Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.8.2 Germany Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.9.2 France Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.9.3 France Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.11.2 Italy Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.12.2 Spain Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.13.2 Russia Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.16.2 China Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.16.3 China Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.17.2 Japan Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.19.2 India Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.19.3 India Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.20.2 Australia Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.24.2 Chile Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.26.2 Peru Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.28.2 Israel Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.29.2 UAE Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.31.2 Iran Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Immobilized Lipase Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Immobilized Lipase Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Immobilized Lipase Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Syncozymes
8.1.1 Syncozymes Comapny Information
8.1.2 Syncozymes Business Overview
8.1.3 Syncozymes Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.1.4 Syncozymes Immobilized Lipase Product Portfolio
8.1.5 Syncozymes Recent Developments
8.2 Yili Chuannig Biotechnology
8.2.1 Yili Chuannig Biotechnology Comapny Information
8.2.2 Yili Chuannig Biotechnology Business Overview
8.2.3 Yili Chuannig Biotechnology Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.2.4 Yili Chuannig Biotechnology Immobilized Lipase Product Portfolio
8.2.5 Yili Chuannig Biotechnology Recent Developments
8.3 Amicogen
8.3.1 Amicogen Comapny Information
8.3.2 Amicogen Business Overview
8.3.3 Amicogen Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.3.4 Amicogen Immobilized Lipase Product Portfolio
8.3.5 Amicogen Recent Developments
8.4 ChiralVision
8.4.1 ChiralVision Comapny Information
8.4.2 ChiralVision Business Overview
8.4.3 ChiralVision Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.4.4 ChiralVision Immobilized Lipase Product Portfolio
8.4.5 ChiralVision Recent Developments
8.5 Novozymes
8.5.1 Novozymes Comapny Information
8.5.2 Novozymes Business Overview
8.5.3 Novozymes Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.5.4 Novozymes Immobilized Lipase Product Portfolio
8.5.5 Novozymes Recent Developments
8.6 Beijing Global Biologicals
8.6.1 Beijing Global Biologicals Comapny Information
8.6.2 Beijing Global Biologicals Business Overview
8.6.3 Beijing Global Biologicals Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.6.4 Beijing Global Biologicals Immobilized Lipase Product Portfolio
8.6.5 Beijing Global Biologicals Recent Developments
8.7 Qingdao Weilan Bio
8.7.1 Qingdao Weilan Bio Comapny Information
8.7.2 Qingdao Weilan Bio Business Overview
8.7.3 Qingdao Weilan Bio Immobilized Lipase Sales, Value and Gross Margin (2020-2025)
8.7.4 Qingdao Weilan Bio Immobilized Lipase Product Portfolio
8.7.5 Qingdao Weilan Bio Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Immobilized Lipase Value Chain Analysis
9.1.1 Immobilized Lipase Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Immobilized Lipase Sales Mode & Process
9.2 Immobilized Lipase Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Immobilized Lipase Distributors
9.2.3 Immobilized Lipase Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.